Sodium polystyrene sulfonate initiation was associated with an increased risk of both severe and minor gastrointestinal events compared with nonuse.
Patients with AKI in the intensive care unit who had low serum sodium accompanied by high serum potassium at hospital admission had a 45% increased risk of 90-day mortality, a study found.
Kidney disease patients associate bananas with potassium, but they need more practical information to manage hyperkalemia.
In separate studies, roxadustat showed superiority over placebo at increasing hemoglobin in patients with CKD anemia and demonstrated noninferiority to epoetin in treating anemia in dialysis patients.
This is the first study examining serum potassium levels in CKD patients treated with sofosbuvir, according to investigators.
In a study, older adult NSAID users had significant 41% and 50% increased odds of AKI and hyperkalemia, respectively, compared with nonusers.
In a phase 2 study of patients with early diabetic nephropathy, esaxerenone decreased microalbuminuria in a dose-dependent manner over 12 weeks compared with placebo.
In a study of hemodialysis patients, pre-operative potassium higher than 3.9 mmol/L correlated with greater risk for hyperkalemia after parathyroidectomy.
In the DIALIZE trial, 41.2% of hemodialysis patients taking sodium zirconium cyclosilicate maintained normal potassium levels during the long interdialytic interval compared with just 1% receiving placebo.
In a study of chronic kidney disease patients not on dialysis, hyperkalemia developed in more women than men.